Slug confers resistance to the epidermal growth factor receptor tyrosine kinase inhibitor (Q39637704)

13 September 2017

title

Slug confers resistance to the epidermal growth factor receptor tyrosine kinase inhibitor (English)

1 reference

13 September 2017

3

Kang-Yi Su

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21037017

17 August 2024

author name string

Tzu-Hua Chang

1

1 reference

13 September 2017

Meng-Feng Tsai

2

1 reference

13 September 2017

Shang-Gin Wu

4

1 reference

13 September 2017

Cheng-Po Huang

5

1 reference

13 September 2017

Sung-Liang Yu

6

1 reference

13 September 2017

Yung-Luen Yu

7

1 reference

13 September 2017

Chou-Chin Lan

8

1 reference

13 September 2017

Chih-Hsin Yang

9

1 reference

13 September 2017

Shwu-Bin Lin

10

1 reference

13 September 2017

Chin-Pyng Wu

11

1 reference

13 September 2017

Jin-Yuan Shih

12

1 reference

13 September 2017

Pan-Chyr Yang

13

1 reference

13 September 2017

language of work or name

English

0 references

publication date

29 October 2010

1 reference

full work available at URL

13 September 2017

http://ajrccm.atsjournals.org/cgi/content/abstract/183/8/1071

online access status

open access

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21037017

American Journal of Respiratory and Critical Care Medicine

17 August 2024

published in

1 reference

13 September 2017

volume

183

1 reference

13 September 2017

issue

8

1 reference

13 September 2017

page(s)

1071-1079

1 reference

Understanding resistance to EGFR inhibitors-impact on future treatment strategies

13 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201009-1440OC

Status of epidermal growth factor receptor antagonists in the biology and treatment of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201009-1440OC

Molecular mechanisms of epidermal growth factor receptor (EGFR) activation and response to gefitinib and other EGFR-targeting drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201009-1440OC

Personalized medicine and inhibition of EGFR signaling in lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201009-1440OC

Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201009-1440OC

EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201009-1440OC

EGFR mutation and resistance of non-small-cell lung cancer to gefitinib

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201009-1440OC

Inhibition of EGFR signaling: all mutations are not created equal

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201009-1440OC

Acquired resistance of lung adenocarcinomas to gefitinib or erlotinib is associated with a second mutation in the EGFR kinase domain

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201009-1440OC

MET amplification leads to gefitinib resistance in lung cancer by activating ERBB3 signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201009-1440OC

Identification of a novel function of TWIST, a bHLH protein, in the development of acquired taxol resistance in human cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201009-1440OC

Chronic oxaliplatin resistance induces epithelial-to-mesenchymal transition in colorectal cancer cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201009-1440OC

Epithelial to mesenchymal transition predicts gefitinib resistance in cell lines of head and neck squamous cell carcinoma and non-small cell lung carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201009-1440OC

Epithelial to mesenchymal transition is a determinant of sensitivity of non-small-cell lung carcinoma cell lines and xenografts to epidermal growth factor receptor inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201009-1440OC

Epithelial versus mesenchymal phenotype determines in vitro sensitivity and predicts clinical activity of erlotinib in lung cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201009-1440OC

Restoring E-cadherin expression increases sensitivity to epidermal growth factor receptor inhibitors in lung cancer cell lines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201009-1440OC

Epithelial to mesenchymal transition contributes to drug resistance in pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201009-1440OC

The malignant pleural effusion as a model to investigate intratumoral heterogeneity in lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201009-1440OC

Transcription repressor slug promotes carcinoma invasion and predicts outcome of patients with lung adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201009-1440OC

Establishment of a human non-small cell lung cancer cell line resistant to gefitinib.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201009-1440OC

Genetic profiling of epithelial cells expressing E-cadherin repressors reveals a distinct role for Snail, Slug, and E47 factors in epithelial-mesenchymal transition

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201009-1440OC

Snail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype?

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201009-1440OC

Slug (SNAI2) down-regulation by RNA interference facilitates apoptosis and inhibits invasive growth in neuroblastoma preclinical models

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201009-1440OC

Slug antagonizes p53-mediated apoptosis of hematopoietic progenitors by repressing puma

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201009-1440OC

Cell death: critical control points

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201009-1440OC

Clinical definition of acquired resistance to epidermal growth factor receptor tyrosine kinase inhibitors in non-small-cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201009-1440OC

Epithelial to mesenchymal transition derived from repeated exposure to gefitinib determines the sensitivity to EGFR inhibitors in A549, a non-small cell lung cancer cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201009-1440OC

The transcription factor snail induces tumor cell invasion through modulation of the epithelial cell differentiation program.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201009-1440OC

Epidermal growth factor receptor activation: how exon 19 and 21 mutations changed our understanding of the pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201009-1440OC

p53 controls cancer cell invasion by inducing the MDM2-mediated degradation of Slug

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201009-1440OC

Clues from worms: a Slug at Puma promotes the survival of blood progenitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201009-1440OC

Slugging it out: fine tuning the p53-PUMA death connection

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201009-1440OC

High-throughput oncogene mutation profiling in human cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201009-1440OC

10.1164/RCCM.201009-1440OC

21 January 2018

Identifiers

DOI

1 reference

13 September 2017

1 reference